Market research

Plant Disease Diagnostics

Explore licenses

360iResearch introduction

Plant Disease Diagnostics: Executive Overview

Plant disease diagnostics combines field observation, laboratory testing, molecular assays, imaging, and digital decision-support tools to identify pathogens and guide crop protection. Its importance is increasing as growers face climate variability, intensified production, resistance management requirements, biosecurity risks, and pressure to reduce unnecessary pesticide use. Effective diagnostics can improve the timeliness and specificity of interventions, support quarantine decisions, and strengthen traceability across agricultural supply chains.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Offering Type

    • Instruments & Hardware
    • Consumables
    • Software & Analytics
    • Services
    View chapter
  2. Chapter 8 Technology

    • PCR-Based Molecular Diagnostics
    • CRISPR-Based Detection
    • Sequencing-Based Diagnostics
    View chapter
  3. Chapter 9 Crop Type

    • Cereals & Grains
    • Fruits & Vegetables
    • Oilseeds & Pulses
    • Cash Crops
    More in this chapter

How Climate, Biosecurity, and Digitalization Are Reshaping Diagnostics

The diagnostic landscape is shifting from symptom-based identification toward integrated workflows that combine visual assessment with immunological, molecular, and image-based methods. Portable testing, connected sensors, remote imaging, and digital sample management are helping move detection closer to farms, nurseries, ports, and processing facilities. At the same time, climate-driven changes in pest and pathogen distribution are increasing the need for surveillance, validated reference materials, standardized protocols, and rapid confirmation of unfamiliar symptoms. Adoption remains dependent on test accuracy, sample quality, operator training, affordability, interoperability, and regulatory acceptance.

Artificial Intelligence Is Strengthening Detection, Triage, and Decision Support

Artificial intelligence is being applied to classify symptoms in images, prioritize samples for laboratory confirmation, identify patterns in surveillance data, and support differential diagnosis. Its strongest practical contribution is likely to be triage: helping users determine which observations require urgent testing and which established protocols should be considered. However, reliable deployment requires representative datasets covering cultivars, growth stages, lighting conditions, mixed infections, nutrient deficiencies, and geographic variation. Human and laboratory validation remain essential because visually similar symptoms, data gaps, model drift, and false negatives can create serious agronomic and biosecurity consequences.

Regional Insights: Uneven Capability, Shared Need for Early Detection

North America combines advanced agricultural research, regulated plant health systems, and broad access to laboratory and digital tools, while fragmented farm structures and cross-border movement require interoperable surveillance. Latin America faces major exposure across export-oriented crops and smallholder systems, making affordable field testing, extension support, and phytosanitary capacity important priorities. Europe emphasizes harmonized regulation, integrated pest management, traceability, and cross-border reporting. The Middle East must manage water constraints, protected cultivation, and imported planting material. Africa requires stronger laboratory networks, last-mile diagnostics, and training alongside scalable mobile and field-based methods. Asia-Pacific presents highly diverse production systems, substantial rice, horticulture, and plantation agriculture, and a strong need to connect national surveillance with farm-level access.

Group Insights: Cooperation Shapes Diagnostic Readiness

ASEAN countries benefit from regional coordination on transboundary diseases, shared protocols, and movement of planting material, although diagnostic capacity varies considerably among members. BRICS cooperation highlights the value of linking large agricultural research systems with practical surveillance and laboratory infrastructure. The European Union prioritizes common standards, coordinated plant-health measures, and data exchange across member states. G7 economies contribute advanced research, regulatory experience, and biosecurity cooperation, while NATO members have an added interest in resilient critical supply chains and coordinated risk management. GCC countries face shared challenges involving arid production, imported inputs, protected agriculture, and rapid pathogen exclusion, making joint procurement, training, and reference laboratories valuable.

Country Insights: Priorities Reflect Crop Systems and Regulatory Capacity

Australia emphasizes biosecurity, quarantine, and protection of geographically distinct production systems. Brazil requires scalable diagnostics across extensive commodity agriculture and diverse tropical environments. Canada prioritizes surveillance across large production areas and climate-sensitive crop regions. China and India need solutions that can serve varied farm sizes, climates, and crop systems while connecting research with extension. France, Germany, Italy, and Spain operate within European plant-health coordination and focus on traceability, integrated management, and high-value crops. Japan and South Korea emphasize precision production, protected cultivation, and rapid response. Mexico faces cross-border trade and diverse climatic risks. Russia requires surveillance across broad agricultural territories. The United Kingdom places strong emphasis on biosecurity, imported plant material, and laboratory-backed monitoring. The United States combines extensive public and private diagnostic infrastructure with complex interstate and international movement controls.

Actions for Industry Leaders: Build Trusted, Accessible Diagnostic Workflows

Leaders should design tiered workflows that match test complexity to the decision at hand: rapid field screening for triage, confirmatory laboratory testing for high-consequence findings, and sequencing or specialized analysis for unresolved cases. They should invest in validated datasets and quality controls before deploying artificial intelligence, establish clear human-override procedures, and measure performance separately by crop, pathogen, geography, and operating condition. Partnerships with growers, laboratories, extension services, regulators, and logistics providers can improve sample integrity and adoption. Interoperable records, transparent reporting, technician training, and cybersecurity should be treated as core infrastructure rather than optional features. Commercial strategies should also account for total workflow cost, recurring consumables, instrument maintenance, and access for smaller producers.

Research Methodology: Evidence-Based Assessment of Diagnostic Priorities

This executive summary synthesizes established evidence from plant-health agencies, peer-reviewed research, international agricultural and biosecurity organizations, regulatory frameworks, and documented technology practices. The assessment compares diagnostic modalities, surveillance requirements, adoption constraints, and regional operating conditions without presenting market estimates or forecasts. Geographic interpretation considers crop diversity, trade exposure, climate pressures, laboratory capacity, regulatory coordination, and farm structure. Artificial intelligence observations are limited to documented applications and recognized implementation requirements, with emphasis on validation, data quality, interpretability, and operational risk.

Conclusion: Faster, More Reliable Diagnosis Supports Resilient Crop Production

Plant disease diagnostics is becoming a foundational capability for sustainable productivity, biosecurity, and supply-chain resilience. The most effective systems will not depend on one test or one algorithm; they will connect field observation, fit-for-purpose assays, laboratory confirmation, digital records, and expert judgment. Regional and international cooperation can reduce duplication and improve response to transboundary threats, while locally accessible services are necessary for practical farm adoption. Industry leaders that prioritize validation, interoperability, affordability, and responsible artificial intelligence will be better positioned to help growers detect disease earlier and intervene more precisely.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Plant Disease Diagnostics Market, by Offering Type
    1. 7.1Introduction
    2. 7.2Instruments & Hardware
      1. 7.2.1PCR Systems
      2. 7.2.2Isothermal Amplification Devices
      3. 7.2.3Imaging & Spectral Sensors
      4. 7.2.4Lateral Flow & Rapid Test Readers
      5. 7.2.5Laboratory Automation & Liquid Handling
    3. 7.3Consumables
      1. 7.3.1Reagents & Master Mixes
      2. 7.3.2Assay Kits & Panels
      3. 7.3.3Sample Collection & Preservation
      4. 7.3.4Extraction & Purification Consumables
    4. 7.4Software & Analytics
    5. 7.5Services
      1. 7.5.1Testing & Diagnostic Services
      2. 7.5.2Field Scouting & Sampling
      3. 7.5.3Training & Technical Support
      4. 7.5.4Method Development & Validation
      5. 7.5.5Maintenance & Calibration
  8. 8.Plant Disease Diagnostics Market, by Technology
    1. 8.1Introduction
    2. 8.2PCR-Based Molecular Diagnostics
    3. 8.3CRISPR-Based Detection
      1. 8.3.1CRISPR-Cas13 Assays
      2. 8.3.2CRISPR-Cas12 Assays
    4. 8.4Sequencing-Based Diagnostics
      1. 8.4.1Amplicon Sequencing
      2. 8.4.2Metagenomics
  9. 9.Plant Disease Diagnostics Market, by Crop Type
    1. 9.1Introduction
    2. 9.2Cereals & Grains
      1. 9.2.1Maize & Corn
      2. 9.2.2Wheat
      3. 9.2.3Rice
      4. 9.2.4Barley & Oats
      5. 9.2.5Sorghum & Millet
    3. 9.3Fruits & Vegetables
      1. 9.3.1Citrus
      2. 9.3.2Apples
      3. 9.3.3Tomatoes
      4. 9.3.4Potatoes
    4. 9.4Oilseeds & Pulses
      1. 9.4.1Soybean
      2. 9.4.2Canola & Rapeseed
      3. 9.4.3Sunflower
      4. 9.4.4Pea & Lentil
      5. 9.4.5Chickpea
    5. 9.5Cash Crops
      1. 9.5.1Sugarcane
      2. 9.5.2Coffee
      3. 9.5.3Cocoa
      4. 9.5.4Tea
      5. 9.5.5Cotton
    6. 9.6Turf & Ornamentals
  10. 10.Plant Disease Diagnostics Market, by Sample Type
    1. 10.1Introduction
    2. 10.2Plant Tissue
      1. 10.2.1Leaf Tissue
      2. 10.2.2Stem & Petiole Tissue
      3. 10.2.3Root Tissue
      4. 10.2.4Fruit & Tuber Tissue
      5. 10.2.5Flower & Reproductive Tissue
    3. 10.3Seed
      1. 10.3.1True Seed
      2. 10.3.2Seed Coatings & Treatments
  11. 11.Plant Disease Diagnostics Market, by Target Pathogen Type
    1. 11.1Introduction
    2. 11.2Fungal
      1. 11.2.1Rusts
      2. 11.2.2Smuts
      3. 11.2.3Wilts
    3. 11.3Bacterial
    4. 11.4Viral
      1. 11.4.1RNA Viruses
      2. 11.4.2DNA Viruses
    5. 11.5Nematode
      1. 11.5.1Root-Knot Nematodes
      2. 11.5.2Cyst Nematodes
      3. 11.5.3Lesion Nematodes
  12. 12.Plant Disease Diagnostics Market, by End User
    1. 12.1Introduction
    2. 12.2Farmers & Growers
    3. 12.3Agronomy & Diagnostic Service Providers
      1. 12.3.1Crop Consultants & Agronomists
      2. 12.3.2Plant Clinics & Diagnostic Centers
      3. 12.3.3Contract Testing Providers
    4. 12.4Research & Academia
    5. 12.5Government & Regulators
    6. 12.6Seed & Breeding Companies
    7. 12.7Agrochemical & Biotech Companies
    8. 12.8Food Supply Chain Operators
  13. 13.Plant Disease Diagnostics Market, by Region
    1. 13.1Introduction
    2. 13.2Asia-Pacific
    3. 13.3Europe
    4. 13.4North America
    5. 13.5Africa
    6. 13.6Latin America
    7. 13.7Middle East
  14. 14.Plant Disease Diagnostics Market, by Group
    1. 14.1Introduction
    2. 14.2NATO
    3. 14.3G7
    4. 14.4European Union
    5. 14.5BRICS
    6. 14.6ASEAN
    7. 14.7GCC
  15. 15.Plant Disease Diagnostics Market, by Country
    1. 15.1Introduction
    2. 15.2United States
    3. 15.3China
    4. 15.4Germany
    5. 15.5Japan
    6. 15.6India
    7. 15.7United Kingdom
    8. 15.8France
    9. 15.9Australia
    10. 15.10Canada
    11. 15.11Italy
    12. 15.12South Korea
    13. 15.13Brazil
    14. 15.14Russia
    15. 15.15Mexico
    16. 15.16Spain
  16. 16.Competitive Landscape
    1. 16.1Market Share Analysis, 2025
    2. 16.2Market Concentration Analysis, 2025
      1. 16.2.1Concentration Ratio (CR)
      2. 16.2.2Herfindahl Hirschman Index (HHI)
    3. 16.3Recent Developments & Impact Analysis, 2025
    4. 16.4Product Portfolio Analysis, 2025
    5. 16.5Benchmarking Analysis, 2025
  17. 17.Company Profiles
    1. 17.1ThermoFisher Scientific Inc.
    2. 17.2Syngenta AG
    3. 17.3Eurofins Scientific SE
    4. 17.4Qiagen N.V.
    5. 17.5SGS SA
    6. 17.6Intertek Group plc
    7. 17.7Bureau Veritas SA
    8. 17.8Yara International ASA
    9. 17.9ALS Limited
    10. 17.10Agilent Technologies, Inc.
    11. 17.11Agdia, Inc.
    12. 17.12PanonIT
    13. 17.13Abingdon Health plc
    14. 17.14Agrisera AB
    15. 17.15Bioreba AG by Calibre Scientific
    16. 17.16Biosense Laboratories AS
    17. 17.17ClearDetections B.V.
    18. 17.18Envirologix Inc. by Ensign-Bickford Industries, Inc.
    19. 17.19Ergobyte Informatics S.A.
    20. 17.20LOEWE Biochemica GmbH
    21. 17.21Merck KGaA
    22. 17.22Miraterra Technologies Corporation
    23. 17.23OptiGene Limited
    24. 17.24Promega Corporation
    25. 17.25Qualiplante SAS
    26. 17.26Romer Labs Division Holding GmbH by DSM-Firmenich AG
    27. 17.27TwistDx Limited
    28. 17.28Vivent SA
  18. 18.Key Experts

Loading the sample request form…